Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Sentman

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targetsJoseph A Wahle, Kim H T Paraiso, Amy L Costello, et al.
Cytotherapy|September 30, 2010
Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collectedKenneth R Meehan, Laleh Talebian, Jillian Wu, et al.
Clinical Immunology (Orlando, Fla.)|May 26, 2007
Unique characteristics of NK cells throughout the human female reproductive tractTeddy F Mselle, Sarah K Meadows, Mikael Eriksson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2012
Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myelomaKenneth R Meehan, Laleh Talebian, Tor D Tosteson, et al.
Cells|September 13, 2025
Human CAR Tregs Targeting SOD1 and Expressing BDNF Reduce Inflammation and Delay Disease in G93A hSOD1-NSG MiceDavid J Graber, W James Cook, Marie-Louise Sentman, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 18, 2008
Human uterine NK cells interact with uterine macrophages via NKG2D upon stimulation with PAMPsSatarupa Basu, Mikael Eriksson, Patricia A Pioli, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Novel mobilization strategies to enhance autologous immune effector cells in multiple myelomaLaleh Talebian, Jia Yan Wu, Dawn A Fischer, et al.
Future Oncology (London, England)|June 15, 2017
Exploiting natural killer group 2D receptors for CAR T-cell therapyBenjamin Demoulin, W James Cook, Joana Murad, et al.
Molecular Cancer Therapeutics|May 14, 2017
NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human TumorsClaire Godbersen, Tiffany A Coupet, Amelia M Huehls, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated MiceMarie-Louise Sentman, Joana M Murad, W James Cook, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targetsJoseph A Wahle, Kim H T Paraiso, Amy L Costello, et al.
Cytotherapy|September 30, 2010
Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collectedKenneth R Meehan, Laleh Talebian, Jillian Wu, et al.
Clinical Immunology (Orlando, Fla.)|May 26, 2007
Unique characteristics of NK cells throughout the human female reproductive tractTeddy F Mselle, Sarah K Meadows, Mikael Eriksson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2012
Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myelomaKenneth R Meehan, Laleh Talebian, Tor D Tosteson, et al.
Cells|September 13, 2025
Human CAR Tregs Targeting SOD1 and Expressing BDNF Reduce Inflammation and Delay Disease in G93A hSOD1-NSG MiceDavid J Graber, W James Cook, Marie-Louise Sentman, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 18, 2008
Human uterine NK cells interact with uterine macrophages via NKG2D upon stimulation with PAMPsSatarupa Basu, Mikael Eriksson, Patricia A Pioli, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Novel mobilization strategies to enhance autologous immune effector cells in multiple myelomaLaleh Talebian, Jia Yan Wu, Dawn A Fischer, et al.
Future Oncology (London, England)|June 15, 2017
Exploiting natural killer group 2D receptors for CAR T-cell therapyBenjamin Demoulin, W James Cook, Joana Murad, et al.
Molecular Cancer Therapeutics|May 14, 2017
NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human TumorsClaire Godbersen, Tiffany A Coupet, Amelia M Huehls, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated MiceMarie-Louise Sentman, Joana M Murad, W James Cook, et al.
Pageof 8